KINSHASA, Democratic Republic of Congo – The Democratic Republic of Congo (DRC) has been forced to delay its much-needed mpox vaccination campaign in the capital, Kinshasa, due to a shortage of vaccine doses. This comes as cases of the disease continue to rise across the country, particularly among children.
The World Health Organization declared mpox a global health emergency in August, as a new strain rapidly spread from Congo to neighboring countries. However, the slow pace of international support, particularly in terms of vaccine and financial aid, has hampered efforts to contain the outbreak.
Cris Kacita, head of operations for Congo’s mpox control program, revealed that the country currently has 53,921 vaccine doses, which are earmarked for high-risk populations in prisons. To launch a vaccination campaign in Kinshasa, which boasts a population of nearly 20 million, the country requires over 162,000 doses.
While vaccination programs are underway in six other provinces, Kinshasa remains vulnerable. France has pledged to supply 100,000 doses, with additional shipments expected from Germany and the African Union. However, the exact delivery timeline for these vaccines remains uncertain.
Kacita attributed the delay in vaccine arrival to various factors, including the bureaucratic process of official requests, manufacturing, documentation, and import authorization. He expressed concern that the shortage could significantly hinder efforts to curb the spread of the disease in Kinshasa’s 14 health zones.
A recent health ministry report indicated a surge in suspected mpox cases, with 1,017 new cases reported between October 28 and November 2. This period also saw 45 confirmed cases and 16 deaths.
Save the Children has raised alarm over the disproportionate impact of mpox on children, who are four times more likely to succumb to the new strain compared to adults. The aid agency’s data shows a 130% increase in suspected child cases since August 14, with the total number reaching 25,600 as of November 3.
Katia Vieira de Moraes LaCasse from Save the Children emphasized the vulnerability of children to mpox, citing their exploratory nature, limited understanding of health guidelines, and weaker immune systems. The organization advocates for targeted vaccination campaigns to protect children and prevent further spread of the disease.
